Humoral Responses and Ex Vivo IFN-γ Production after Canine Whole Blood Stimulation with

cell-mediated immunity diagnosis dog leishmaniosis serology

Journal

Veterinary sciences
ISSN: 2306-7381
Titre abrégé: Vet Sci
Pays: Switzerland
ID NLM: 101680127

Informations de publication

Date de publication:
04 Mar 2022
Historique:
received: 15 12 2021
revised: 22 02 2022
accepted: 26 02 2022
entrez: 24 3 2022
pubmed: 25 3 2022
medline: 25 3 2022
Statut: epublish

Résumé

The effect of Leishmania infantum soluble antigen (LSA) and recombinant Kinetoplastid Membrane Protein 11 (rKMP11) on the induction of ex vivo specific IFN-γ (n = 69) and antibody responses (n = 108) was determined in dogs. All dogs were tested for serological response to both antigens and divided into Group 1: healthy (Asturias, Spain, n = 26), Group 2: sick (n = 46), Group 3: healthy Ibizan hounds (Mallorca, Spain, n = 22) and Group 4: healthy (Bari, Italy, n = 14). Antibody levels were higher for LSA when compared to rKMP11 (p = 0.001). Ibizan hounds were all seronegative to rKMP11 and 18% were low seropositive to LSA. Sick dogs presented higher antibody response to both antigens compared to the rest of the groups (p < 0.0001). All groups showed higher IFN-γ levels after LSA compared to rKMP11 responses (p < 0.05). The highest response to LSA was found in Ibizan hounds (p < 0.05). IFN-γ to LSA and rKMP11 stimulation was observed in 34% and in 2.8% of the sick dogs, respectively. Here, we demonstrated that anti-rKMP11 antibodies are mainly present in dogs with moderate to severe disease. Furthermore, cellular immune response measured by specific ex vivo IFN-γ production was more intense to LSA than stimulated to rKMP11.

Identifiants

pubmed: 35324844
pii: vetsci9030116
doi: 10.3390/vetsci9030116
pmc: PMC8954708
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Spanish ministry grant, Ministerio de Economía y competitividad and Fondo Europeo de Desar-rollo Regional (FEDER, EU)
ID : AGL2015-68477

Références

Vet Parasitol. 2013 Mar 31;193(1-3):71-7
pubmed: 23261089
Biochem J. 1995 Jan 1;305 ( Pt 1):307-13
pubmed: 7826346
Mol Biochem Parasitol. 1995 Apr;71(1):1-13
pubmed: 7630374
Trends Parasitol. 2010 Jul;26(7):341-9
pubmed: 20488751
Vet Sci. 2020 Sep 04;7(3):
pubmed: 32899831
PLoS Negl Trop Dis. 2017 Nov 27;11(11):e0005951
pubmed: 29176865
Euro Surveill. 2010 Mar 11;15(10):19505
pubmed: 20403308
Vet Parasitol. 2014 Oct 15;205(3-4):472-82
pubmed: 25234767
J Immunol. 2005 Jun 1;174(11):7160-71
pubmed: 15905560
Vet Parasitol. 2017 Dec 15;248:39-47
pubmed: 29173539
PLoS One. 2016 May 12;11(5):e0155224
pubmed: 27171409
J Immunol. 1992 Jan 1;148(1):202-7
pubmed: 1370169
Infect Immun. 1994 Jan;62(1):229-35
pubmed: 8262632
Afr Health Sci. 2019 Mar;19(1):1329-1337
pubmed: 31148958
Parasit Vectors. 2014 Mar 24;7:111
pubmed: 24655335
Biochim Biophys Acta. 1998 Nov 8;1442(2-3):230-7
pubmed: 9804960
Vet J. 2014 Dec;202(3):425-35
pubmed: 25266647
Vet Parasitol. 2015 Apr 30;209(3-4):157-63
pubmed: 25825146
Parasit Vectors. 2020 Jun 10;13(1):301
pubmed: 32522246
PLoS One. 2013 Oct 11;8(10):e73873
pubmed: 24146743
Trends Parasitol. 2017 Sep;33(9):706-717
pubmed: 28689776
Vet Immunol Immunopathol. 2002 Sep 6;88(1-2):21-30
pubmed: 12088641
Rev Soc Bras Med Trop. 2018 Mar-Apr;51(2):190-197
pubmed: 29768552
Scand J Immunol. 2005 Apr;61(4):337-42
pubmed: 15853916
Parasit Vectors. 2009 Mar 26;2 Suppl 1:S1
pubmed: 19426440
Prev Vet Med. 2019 Jan 1;162:67-75
pubmed: 30621900
Vet Parasitol. 2009 Oct 28;165(1-2):1-18
pubmed: 19559536
Methods Mol Biol. 2019;1855:31-39
pubmed: 30426404
Immunobiology. 2014 Apr;219(4):323-8
pubmed: 24571797
Vet Immunol Immunopathol. 1999 Aug 2;69(2-4):121-6
pubmed: 10507299
Vet Parasitol. 1999 Jul;84(1-2):33-47
pubmed: 10435789
Parasite Epidemiol Control. 2019 Nov 21;8:e00126
pubmed: 31832561
Parasit Vectors. 2016 May 10;9(1):235
pubmed: 27160317
Mem Inst Oswaldo Cruz. 2010 May;105(3):341-7
pubmed: 20512252
DNA Cell Biol. 2000 Jan;19(1):47-57
pubmed: 10668791
J Biol Inorg Chem. 2001 Jan;6(1):107-17
pubmed: 11191218
Expert Rev Vaccines. 2018 Apr;17(4):323-334
pubmed: 29589966
Int J Parasitol. 2005 Jan;35(1):63-73
pubmed: 15619517
Vaccine. 2008 Mar 28;26(15):1902-11
pubmed: 18321614
Res Vet Sci. 2020 Jun;130:19-25
pubmed: 32109759
Parasit Vectors. 2012 Mar 27;5:60
pubmed: 22452948
Clin Vaccine Immunol. 2010 Feb;17(2):267-73
pubmed: 20032217
Parasit Vectors. 2016 Jun 03;9(1):317
pubmed: 27260142

Auteurs

Pamela Martínez-Orellana (P)

Departament de Medicina i Cirurgia Animal, Facultat de Veterinària, Universitat Autònoma de Barcelona, 08193 Bellaterra, Spain.

Noemí González (N)

Departament de Medicina i Cirurgia Animal, Facultat de Veterinària, Universitat Autònoma de Barcelona, 08193 Bellaterra, Spain.

Antonella Baldassarre (A)

Dipartimento delle Emergenze e dei Trapianti d' Organo, Sezione Cliniche Veterinarie, Università degli Studi di Bari Aldo Moro, 70124 Bari, Italy.

Alejandra Álvarez-Fernández (A)

Departament de Medicina i Cirurgia Animal, Facultat de Veterinària, Universitat Autònoma de Barcelona, 08193 Bellaterra, Spain.

Laura Ordeix (L)

Departament de Medicina i Cirurgia Animal, Facultat de Veterinària, Universitat Autònoma de Barcelona, 08193 Bellaterra, Spain.

Paola Paradies (P)

Dipartimento delle Emergenze e dei Trapianti d' Organo, Sezione Cliniche Veterinarie, Università degli Studi di Bari Aldo Moro, 70124 Bari, Italy.

Manuel Soto (M)

Departamento Biología Molecular, Centro Biología Molecular Severo Ochoa, Universidad Autónoma de Madrid, 28049 Madrid, Spain.

Laia Solano-Gallego (L)

Departament de Medicina i Cirurgia Animal, Facultat de Veterinària, Universitat Autònoma de Barcelona, 08193 Bellaterra, Spain.

Classifications MeSH